|
Real-time Estimate
Cboe BZX
12:32:52 08/10/26 am AEDT
|
5-day change | 1st Jan Change | ||
| 24.17 USD | -0.45% |
|
-5.34% | +1.89% |
| 23/09 | Arcus Biosciences, Inc. Announces New Data for Casdatifan as Treatment for Kidney Cancer Across Multiple Lines of Therapy | CI |
| 16/09 | TD Cowen Initiates Arcus Biosciences at Buy | MT |
Stock exchange
Quotes 5-day view: Arcus Biosciences, Inc.
Delayed Quote NYSE
| 01/10/2026 | 02/10/2026 | 05/10/2026 | 06/10/2026 | 08/10/2026 | |
|---|---|---|---|---|---|
| Last | USD 25.23 | USD 24.44 | USD 24.74 | USD 24.28 | USD 24.28 |
| Volume | 1,362,744 | 1,041,906 | 1,390,862 | 824,849 | 824,849 |
| Change | -2.32% | -3.13% | +1.23% | -1.86% | -0.45% |
| Opening | USD 25.86 | USD 25.48 | USD 24.19 | USD 24.96 | USD 24.96 |
| High | USD 26.26 | USD 25.58 | USD 24.95 | USD 24.96 | USD 24.96 |
| Low | USD 25.13 | USD 24.09 | USD 24.11 | USD 23.96 | USD 23.96 |
Performance
| 1 day | -0.45% | ||
| 1 week | -5.34% | ||
| Current month | -6.00% | ||
| 1 month | -18.14% | ||
| 3 months | -19.01% | ||
| 6 months | +9.17% | ||
| Current year | +1.89% | ||
| 1 year | +67.68% | ||
| 3 years | +45.30% | ||
| 5 years | -27.91% |
Volumes
marketsDaily volume
824,849
Estimated daily volume
824,849
Avg. Volume 20 sessions
1,640,291
Daily volume ratio
0.5
Avg. Volume 20 sessions USD
39,645,833.47
Record volume 1
13,084,990
Record volume 2
8,205,638
Record volume 3
7,623,113
Capital turnover ratio
0.01
Float rotation
0.02
Basic data
Market Cap (USD)
3,091,654,369
Net sales (USD)
247,000,000
Number of employees
601
Sales / Employee (USD)
410,982
Free-Float
71.2%
Free-Float capitalization (USD)
2,201,339,571
Average Daily Capital Traded
1.28%
Indicators
Moving average 5 days
24.9
Moving average 20 days
25.61
Moving average 50 days
27.72
Moving average 100 days
27.09
Price spread / (MMA5)
+3.04%
Price spread / (MMA20)
+5.97%
Price spread / (MMA50)
+14.69%
Price spread / (MMA100)
+12.06%
STIM
RSI 9 days
38.67
RSI 14 days
39.49
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.45% | -5.34% | +67.68% | +45.30% | 3.09B | |
| +4.16% | +4.16% | +49.37% | +94.17% | 74.69B | |
| -0.05% | -1.32% | +23.06% | +78.93% | 58.81B | |
| 0.00% | +0.38% | +6.89% | +34.59% | 48.45B | |
| -1.72% | -2.25% | +329.09% | +698.20% | 42.84B | |
| +0.27% | -3.35% | +26.81% | +30.88% | 42.79B | |
| -0.56% | -0.68% | +5.30% | +108.64% | 41.25B | |
| -0.11% | +1.96% | +9.19% | +52.66% | 31.13B | |
| -2.07% | +1.16% | +35.00% | +26.28% | 30.28B | |
| -1.03% | -2.88% | -8.97% | -13.92% | 24.05B | |
| Average | -0.10% | -0.76% | +54.34% | +115.57% | 39.74B | |
| Weighted average by Cap. | +0.39% | -0.58% | +55.82% | +129.11% |
Historical Quotes: Arcus Biosciences, Inc.
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Price Extremes
| 1 week | 23.96 |  | 26.26 |
| 1 month | 23.31 | | 29.5 |
| Current year | 18.52 | | 31.74 |
| 1 year | 14.18 | | 31.74 |
| 3 years | 6.5 | | 31.74 |
| 5 years | 6.5 | | 49.1 |
| 10 years | 6.3 | | 49.1 |
Monthly variations
Annual variations
| 2026 | +1.89% | ||
| 2025 | +60.04% | ||
| 2024 | -22.04% | ||
| 2023 | -7.64% | ||
| 2022 | -48.90% | ||
| 2021 | +55.89% | ||
| 2020 | +157.03% | ||
| 2019 | -6.22% | ||
| 2018 | -36.65% |
- Stock Market
- Stocks
- RCUS Stock
- Quotes Arcus Biosciences, Inc.
Select your edition
All financial news and data tailored to specific country editions
